clinical experience and laboratory tests in 52 patients ( 14 to 77 years of age ) who had moderate to severe ear , nose , and throat infections were evaluated in this study of cefaclor , a new cephalosporin antibiotic , the drug proved to be effective in the treatment of these infections , and the incidence of side effects was low .
C0031350
throat infections
C0007537
cefaclor